The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Machina Capital S.A.S.

Machina Capital S.A.S. increased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 363.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,936 shares of the medical device company's stock after acquiring an additional 13,282 shares during the period. Machina Capital S.A.S.'s holdings in Cooper Companies were worth $1,557,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in COO. Stephens Inc. AR raised its stake in shares of Cooper Companies by 16.9% in the third quarter. Stephens Inc. AR now owns 3,570 shares of the medical device company's stock valued at $394,000 after acquiring an additional 516 shares during the period. Asset Management One Co. Ltd. lifted its stake in Cooper Companies by 1.2% in the third quarter. Asset Management One Co. Ltd. now owns 80,149 shares of the medical device company's stock worth $8,844,000 after purchasing an additional 964 shares during the last quarter. Graypoint LLC purchased a new stake in Cooper Companies in the third quarter worth $233,000. Principal Financial Group Inc. boosted its stake in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after purchasing an additional 14,687 shares during the period. Finally, Portside Wealth Group LLC grew its holdings in shares of Cooper Companies by 6.5% in the third quarter. Portside Wealth Group LLC now owns 10,157 shares of the medical device company's stock worth $1,121,000 after purchasing an additional 624 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Cooper Companies Stock Down 2.4 %

Shares of COO stock traded down $1.96 during trading hours on Wednesday, reaching $79.07. 2,875,364 shares of the company's stock were exchanged, compared to its average volume of 1,724,939. The Cooper Companies, Inc. has a fifty-two week low of $78.43 and a fifty-two week high of $112.38. The stock's 50 day moving average is $91.93 and its 200-day moving average is $99.25. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market cap of $15.78 billion, a price-to-earnings ratio of 40.55, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on COO shares. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $111.89.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.